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Abstract
The relative promiscuity of hub proteins such as postsynaptic density protein-95 (PSD-95) can be achieved by alternative
splicing, allosteric regulation, and post-translational modifications, the latter of which is the most efficient method of
accelerating cellular responses to environmental changes in vivo. Here, a mutational approach was used to determine the
impact of phosphorylation and succinimidation post-translational modifications on the binding affinity of the postsynaptic
density protein-95/discs large/zonula occludens-1 (PDZ3) domain of PSD-95. Molecular dynamics simulations revealed that
the binding affinity of this domain is influenced by an interplay between salt-bridges linking the a3 helix, the b2–b3 loop
and the positively charged Lys residues in its high-affinity hexapeptide ligand KKETAV. The a3 helix is an extra structural
element that is not present in other PDZ domains, which links PDZ3 with the following SH3 domain in the PSD-95 protein.
This regulatory mechanism was confirmed experimentally via thermodynamic and NMR chemical shift perturbation
analyses, discarding intra-domain long-range effects. Taken together, the results presented here reveal the molecular basis
of the regulatory role of the a3 extra-element and the effects of post-translational modifications of PDZ3 on its binding
affinity, both energetically and dynamically.
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Introduction
One of the most ambitious goals of modern biology is to
understand protein networks that regulate complex cellular
processes. The main distinctive feature of these networks is the
presence of hubs and super-hubs that undergo hundreds or
thousands of different interactions [1]. Such proteins are able to
recognise and distinguish between a variety of targets, are
evolutionary conserved, and play central roles in specific processes
[2]. Promiscuity of hub proteins can be achieved in a number of
different ways; for example, alternative splicing can lead to the
generation of a large number of isomers that enable multiple
protein-protein interactions [3,4]. Allosteric regulation and post-
translational modifications constitute a way of multiplying
functionalities by modulating the affinities and specificities of
protein binding sites. In fact, post-translational modifications are
the most efficient method to accelerate the cellular response to
environmental changes [5].
Members of the membrane-associated guanylate kinase (MA-
GUK) family, including postsynaptic density protein-95 (PSD-95;
also known as SAP-90 or DLG-4), are known hub proteins.
MAGUKs lack enzymatic activity and are structurally organised
into several conformationally-independent modular domains that
are interconnected by relatively short amino acid sequences; these
domains typically comprise three postsynaptic density protein-95/
discs large/zonula occludens-1 (PDZ) domains, one SH3 domain
and one kinase domain (Figure 1). Structural modelling of the
multi-modular organisation of PSD-95 has revealed that the
protein develops a level of functional regulation through high
conformational plasticity that is achieved mainly by the inter-
domain sequences [6]. The term ‘supertertiary structure’ has been
proposed to describe the multiplicity of conformations and states
of these multi-modular proteins that might coexist and interchange
under equilibrium conditions [7,8].
An a-helical segment in PSD-95 (Figures 1 and 2; a3 helix),
which connects the PDZ3 domain to the subsequent SH3 domain,
packs the PDZ3 domain at a different face to that of the binding
pocket, thereby enabling allosteric modulation of the protein, as
demonstrated by a 21-fold drop in affinity for the C-terminal
sequence of cysteine-rich PDZ-binding protein (CRIPT) after
removal of the a3 helix [9]. A recent nuclear magnetic resonance
(NMR) and small-angle X-ray scattering study of the tandem
PDZ3-SH3 in PSD-95 demonstrated that the PDZ3 domain
favours an orientation where its ligand binding site faces the SH3
domain, although this inter-domain interaction appears to be weak
[10]. In this context, the a3 linking element can be positioned
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between the PDZ3 and SH3 domains or away from both of them
when a C-terminal partner of PDZ3 displaces their weak
interaction. Phospho-mimicking mutations at residues Tyr397
(located in the a3 helix), Ser415, and Ser418 of PSD-95 also
weaken the interaction between the PDZ3 and SH3 domains [11].
PSD-95 can be phosphorylated at these sites in mouse brain, but
very little is known about the consequences of these modifications
in vivo. Considering that phosphorylation is the most common
post-translational modification of proteins, the accumulation of
phosphorylation sites in PSD-95 suggests that the a3-helix region
is a key target for MAGUK regulation in vivo [11].
We demonstrated previously that residue Asp332 at the b2–b3
loop of the PDZ3 domain in PSD-95 (Figure 2) can undergo post-
translational cyclation of its side chain after nucleophilic attack
[12]. Succinimide ring formation, despite occurs spontaneously
in vivo as an intermediate step in Asp isomerisation and Asn
deamidation [13], likely has a functional role. For example, in the
case of Asn, succinimide formation leads to spontaneous mutation
to Asp [14]; also, c-S crystallin deposits found in ocular cataracts
are a consequence of reduced solubility of the protein caused by
the succinilation of its Asn residues [15]. Accordingly, it has been
proposed that spontaneous Asp to succinimide to iso-Asp
transformations are associated with a higher b-aggregation
tendency of some peptides [16], including the Alzheimer’s disease
Ab peptide [17]. The biological relevance of these post-transla-
tional modifications is underlined by the ubiquitous presence of D-
aspartyl/L-isoaspartyl methyltransferase activity that renovates the
Asp residues from succinimides and iso-Asp, thus avoiding possible
negative consequences [18]. The half-life of succinimide rings is in
the order of 1 hour, although it is affected by pH, ionic strength,
electrophiles, and solvent polarity and viscosity [14]. This high
degree of stability may be sufficient to influence protein activity
and/or ligand binding. In the case of the PSD-95-PDZ3 domain,
the succinimide ring reduces the flexibility of the b2–b3 loop and
results in a loss of negative charge from the Asp332 side chain.
These findings suggest that such post-translational modifications
are candidate regulators of the binding affinity of the PDZ3
domain in PSD-95.
Here, isothermal titration calorimetry (ITC), NMR and
molecular dynamics (MD) simulations were used to study the
interaction between the PDZ3 domain in PSD-95 and the
consensus hexapeptide KKETAV, which is the highest affinity
binding partner of PSD-95 identified to date [19]. In addition, we
have explored by site-directed mutagenesis, using experimental
and computational approaches, the energetic and dynamic impact
of phosphorylation at Tyr397 (P397-PDZ3) and succinimidation of




The plasmids encoding the PDZ3 mutants (Table 1) were
derived from a wild-type PDZ3 plasmid (including residues 302–
403 of the full PSD-95 protein) [20] using the QuikChange Site-
Directed Mutagenesis Kit (Agilent). The 10ct-PDZ3 construct
(residues 302–393 of the full PSD-95 protein) was obtained by
PCR amplification, as described previously [21]. All proteins were
overexpressed in Escherichia coli BL21/DE3 and purified as
described previously [20,22]. The KKETAV peptide used for
ITC was purchased from Peptide 2.0 (USA). For NMR analyses,
the samples were prepared by dissolving lyophilised protein, which
was previously dialysed against water, in potassium phosphate
buffer (pH 7.5) and then readjusting the pH. For all other
analyses, the samples were prepared by extensive dialysis against a
large volume of the same buffer. Protein concentrations were
determined by measuring UV absorbance at 278 nm, using an
extinction coefficient of 1492 cm21?M21 (Y397E-PDZ3 only) or
2985 cm21?M21 (all other proteins). These extinction coefficients
were estimated as described previously [23]. The molecular
weights and purities of the proteins were confirmed by MALDI-
TOF performed by the CIC services of the University of Granada.
Isothermal Titration Calorimetry
Calorimetric titrations of the wild-type and mutant PDZ3 with
the KKETAV peptide were performed at 25uC on an ITC-200
titration microcalorimeter (Microcal Inc.). The protein concen-
trations in the cell were either 70 mM (for wild-type PDZ3,
E401R-PDZ3, E334Q-PDZ3, D332G-PDZ3, Y397E-PDZ3, and
D10ct-PDZ3) or 200 mM (for D332P-PDZ3). The KKETAV
ligand solution was prepared at 3 mM (for D332P-PDZ3) or
900 mM (for wild-type PDZ3 and the remainder of the mutants) by
dissolving the lyophilised peptide in the dialysis buffer and then
readjusting the pH. Titrations were made by a series of injections
of 2 ml of ligand solution (Figure S1). As a reference, an
independent experiment in which the calorimeter cell contained
buffer only was performed with the same ligand solution to
determine the corresponding heat dilution. The dilution isotherm
was subtracted from that obtained for the protein titration. The
binding stoichiometry (n), the dissociation constant (Kd), and the
corresponding enthalpy change (DH) were determined by fitting
the resulting titration isotherm to a single set of identical sites
binding model using ORIGIN software (OriginLab).
Nuclear Magnetic Resonance
The 1H-15N correlation spectra were carried out at 25uC on a
Varian NMR Direct-Drive System 600 MHz spectrometer (1H
frequency of 600.25 MHz) equipped with a cryoprobe. The
protein concentration was 100 mM and the results were recorded
in 90% H2O/10% D2O containing 50 mM potassium phosphate
buffer (pH 7.5). For the free and bounds forms of PDZ3 and
D10ct-PDZ3, backbones were assigned using standard triple-
resonance methodologies. All NMR experiments were processed
using NMRPipe software [24] and analysed using SPARKY
software [25]. The 15N and 1H chemical shift perturbations








Figure 1. The ‘supertertiary’ structure of PSD-95 protein.
doi:10.1371/journal.pone.0090030.g001
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Figure 2. The structure and sequence of the PDZ3 domain of PSD-95. The panel on the upper left shows a structural representation of the
PDZ3 domain of PSD-95 in complex with the hexapeptide KKETAV (orange), modelled from the X-ray structure of the PDZ3-CRIPT complex (Protein
Data Bank ID: 1BE9). The a1, a2, and a3 helices are shown in green, light blue and blue, respectively. The b2–b3 loop is shown in red and the b2 chain
is shown in yellow. The dashed line indicates the binding pocket. The panel on the upper right is a detailed view of the interface of the a3 helix at the
C-terminus of PDZ3 showing the spatial arrangement of the Phe, Tyr, Asp, and Glu residues. The lower panel shows the sequence of the PDZ3 domain
and its secondary structures. Numbering of the protein residues is relative to their positions in the full-length PSD-95 protein. Numbering of the
KKETAV peptide residues is from 0 (C-terminal Val residue) to 25 (N-terminal Lys residue).
doi:10.1371/journal.pone.0090030.g002
Table 1. Thermodynamic parameters of the interaction between PSD-95-PDZ3 and various ligands determined by ITCa.
n Kd (mM) DH (kcal?mol21) 2TDS (kcal?mol21) DG (kcal?mol21)
PDZ3/KKETAVb 0.99 1.5 29.8 1.8 28.0
PDZ3/KKETAVc 1.00 0.45 25.3 23.4 28.7
PDZ3/YKQTSV CRIPTd 0.80 1.0 210.0 1.9 28.1
D7ct -PDZ3/YKQTSV CRIPTd 0.90 6.0 23.4 23.7 27.1
D10ct-PDZ3/KKETAVb 0.90 3.6 28.8 1.4 27.4
E334Q-PDZ3/KKETAVb 1.09 2.9 29.8 2.2 27.6
E401R-PDZ3/KKETAVb 1.10 1.5 29.2 1.2 28.0
Y397E-PDZ3/KKETAVb 0.98 2.7 27.4 20.2 27.6
PDZ3/NYKQTSV CRIPTe 0.98 3.6 28.6 1.2 27.4
P397-PDZ3/NYKQTSV CRIPTe 0.99 14.0 28.8 2.2 26.6
D332P-PDZ3/KKETAVb 1.05 16.0 27.9 1.4 26.5
D332G-PDZ3/KKETAVb 1.01 2.2 28.7 1.0 27.7
aExamples of the ITC experiments are shown in Figures 3 and S1. The variability in the experimental values was estimated to be approximately 1% for the number of
binding sites, 5% for the binding enthalpy, and 10% for the binding affinity [29].
bThe experimental conditions were 50 mM potassium phosphate (pH 7.5) at 25uC.
cThe experimental conditions were 20 mM MES (pH 6.0) and 10 mM NaCl, at 25uC [19].
dThe experimental conditions were 50 mM potassium phosphate (pH 7.5) at 25uC [28].
eThe experimental conditions were 20 mM sodium phosphate (pH 6.8), 50 mM NaCl, and 1 mM EDTA, at 25uC [11].
doi:10.1371/journal.pone.0090030.t001
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Model Building and Molecular Dynamics
The X-ray structure of the PDZ3 domain bound to CRIPT
(Protein Data Bank ID: 1BE9) was used as a template to build the
model structures. To produce the coordinate files of the different
experimental constructs, the C-terminal segment of PDZ3
(residues 404–415) was removed and the missing side chains were
rebuilt using the design tools in Discovery Studio 2.1 Suite
(Accelrys Software Inc.). To model the KKETAV ligand, the
CRIPT sequence was modified as follows: the N-terminal residue
was replaced by a Lys residue, Gln-3 was replaced by Glu, Ser-1
was replaced by Ala and a Val residue was added to the C-
terminus. Numbering of the KKETAV peptide residues was from
0 (C-terminal Val residue) to 25 (N-terminal Lys residue). Finally,
the structure was subjected to energy minimisation by the steepest
descent algorithm implemented in the CHARMM simulation and
analysis package. To obtain the structures of the D332P-PDZ3,
Y397E-PDZ3, and P397-PDZ3 proteins, the side chains of the
target mutated residues were modified using Discovery Studio 2.1
Suite and all models were subjected to energy minimisation using
the same algorithm as that used for PDZ3.
To produce 400 ns MD simulations for the different structures,
NAMD software (version 2.7b1) [26] was selected using the
CHARMM22 force field. The starting structures were solvated in
a 60660660 Å3 truncated octahedron box of water with the
CHARMM scientific package [27]. Once solvation was complete,
the structure was neutralised by replacing a number of water
molecules with counter-ions to achieve the desired concentration
of ions (150 mM solution of potassium chloride). The system was
then minimised with a harmonic restraint at the protein atoms and
crystallographic water molecules for 2000 steps, the latter to
remove bad contacts of water molecules. Finally, the full system
was equilibrated by carrying out conventional MD simulations
with gradually weaker constraints every 1 ns on the structure (up
to 4 ns).
All trajectories were generated at a constant temperature
(298 K) and pressure (1 atm), under periodic-boundary condi-
tions. Electrostatic interactions were computed using the Particle
Mesh-Ewald algorithm with a real-space cut-off distance of 12 Å;
this cut-off was used for the van der Waals interactions. To control
temperature and pressure, the Langevin scheme was used and MD
trajectories were recorded every 2 ps. The simulations were
performed on the University of Granada’s UGRGrid supercom-
puter (a Sun Fire X2200/X4600 cluster) using 64 CPUs for each
trajectory. The figures were prepared using VMD software
(University of Illinois, USA).
For salt-bridge definitions, ionic interactions were considered to
occur when the two last carbons before the charged atoms were
closer than 5 Å. We confirmed that this approach generates
equivalent results to those generated considering a 4 Å cut-off
distance of the charged atoms mass centers.
Results and Discussion
Electrostatic Interactions between N-terminal Residues in
the Ligand and the b2–b3 Loop of PSD-95-PDZ3 are
Essential for Binding
To gain insight into the molecular determinants of the
interactions between the PDZ3 domain of PSD-95 and its ligands,
detailed thermodynamic and dynamic characterisations of the
complex between the hexapeptide KKETAV and PSD-95-PDZ3
were performed. The KKETAV ligand was designed and
optimised by Spaller and colleagues [19]. To our knowledge, it
is the highest affinity binding partner of PSD-95-PDZ3 described
to date, which demonstrates that a six-residue peptide is sufficient
to capture maximal binding affinity of the PSD-95-PDZ3 domain
[19,28]. Interactions outside of the binding pocket of PSD-95-
PDZ3 (Figure 2) may also be possible sources of binding specificity,
as reported for other modular domains, such as the SH3 domain
of the c-Abl oncogene [29].
The binding energetics of the PDZ3/KKETAV complex was
measured directly using ITC. The upper panel in Figure 3 shows
an example of a calorimetric titration of KKETAV to PSD-95-
PDZ3 in 50 mM potassium phosphate buffer at pH 7.5. The
corresponding binding isotherm is shown in the lower panel of
Figure 3, together with the best fit to a one set of sites model [29].
Under these conditions, KKETAV bound to a single site with a
dissociation constant of 1.5 mM (Table 1), which is approximately
three times higher than that reported previously for the same
ligand at pH 6.0 [19] (Table 1), suggesting that electrostatic
interactions between charged residues play an important role in
binding of PSD-95-PDZ3 to KKETAV. As shown in Table 1, the
higher binding affinity at pH 6.0 is related to entropic contribu-
tions, which are favourable to binding at pH 6.0 but unfavourable
at pH 7.5 (2TDDS = 5.2 kcal?mol21). This entropy change
overcomes the favourable contributions to binding originated
from a more negative binding enthalpy at pH 7.5
(DDH = 4.5 kcal?mol21), reflecting the establishment of optimised
interactions at higher pH.
Analysis of a structural model generated by homology modelling
of the PDZ3/KKETAV complex suggested that the pH depen-
dency of the binding affinity is associated with the ionisation state
Figure 3. Calorimetric titration of the PSD-95-PDZ3 domain
with the KKETAV ligand. Example of a calorimetric titration of
KKETAV to PSD-95-PDZ3 at 25uC in 50 mM potassium phosphate
(pH 7.5). The upper panel shows the net heat effects (after dilution
subtraction) associated with the injection of KKETAV. The lower panel
shows the ligand concentration dependence of the heat released upon
binding after normalisation and correction for the heats of dilution. The
trend line shows the best fit to a model considering one set of binding
sites.
doi:10.1371/journal.pone.0090030.g003
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of His372 (pKa ,6), which is located in the a2 helix and is
implicated in the formation of a highly optimised hydrogen bond
with the side chain of the Thr residue in KKETAV (Figure 2).
This interaction also occurs during binding of the CRIPT peptide
to PSD-95-PDZ3 [30] and is considered a key interaction in class I
PDZ domains [31]; however, to our knowledge, the energetic
consequences of pH changes on this interaction have not yet been
evaluated. Considering the lack of other titratable residues within
this pH range in the vicinity of the PSD-95-PDZ3 binding site, and
the fact that no substantial differences in stability and folding
behaviour have been observed for the domain between pH 4.0
and pH 7.5 [32], it is reasonable to argue that entropic differences
might arise from changes in the conformational entropy of ligand
side chains interacting with His372 and not from significant
conformational changes in the PDZ3 domain.
Next, an NMR titration analysis was performed to determine
which residues in PSD-95-PDZ3 are required for the recognition
of KKETAV. It is possible to determine which residues participate
in the interaction by monitoring the changes in their respective
chemical shifts, because the chemical shift of every residue is
related to the chemical environment surrounding the respective
amide group. A series of 1H-15N heteronuclear single quantum
coherence (HSQC) spectra were collected at different concentra-
tions of KKETAV. As expected, marked chemical environment
perturbations were identified for residues located in the vicinity of
the binding groove of PSD-95-PDZ3 (Figures 4 and S2). However,
the strongest effects were observed for residues 329–334, which are
located in the b2–b3 loop. Interactions between residues in this
loop of PSD-95-PDZ3 and the side chain of Lys-4 in KKETAV
have been proposed previously [33]. Furthermore, binding studies
have revealed a determinant role of Lys-4 in the binding affinity of
KKETAV, although this interaction was not observed in the
crystal structure of the complex due to lack of resolution of the
Lys-4 side chain [19]. Consequently, to our knowledge, the results
presented here are the first experimental proof that Lys-4 in
KKETAV is essential for binding, most likely due to its interaction
with the Glu331, Asp332, and Glu334 residues in PSD-95-PDZ3.
The interactions between residues at the N-terminus of
KKETAV and the PDZ3 domain of PSD-95 were analysed
further by performing MD simulations of the PDZ3/KKETAV
complex. The results of this analysis are shown in Figure 5 and
Table 2. Analysis of the 400 ns trajectory revealed that Lys-4 in
KKETAV is involved in charge-charge interactions with Glu331
in the b2–b3 loop (observed for 37% of the simulation time) and
Glu373 in the a2 helix (observed for 20% of the simulation time)
of PSD-95-PDZ3. Glu331 and Glu334 in the b2–b3 loop of PSD-
95-PDZ3 also interacted frequently with Lys-5 in KKETAV (20%
and 36% of the simulation time, respectively), suggesting a
relevant contribution of this Lys residue to the interaction. This
observation is in agreement with those of previous ITC studies,
which showed that adding an N-terminal Lys residue to the
KETEV sequence increases the binding affinity for the PDZ3
domain of PSD-95 by an order of magnitude [34]. As shown in
Table 1, elimination of the charge at position 334 of PSD-95-
PDZ3 by introduction of the E334Q mutation caused a two-fold
reduction in its binding affinity for KKETAV that was of entropic
origin, which is typical of electrostatic interactions [35]. Globally,
through this collection of salt-bridges, the interaction between the
b2–b3 loop of the PSD-95-PDZ3 domain and the N-terminal
region of the peptide ligand was maintained for more than 75% of
the simulation time (Table 2).
The a3 extra-helix regulates ligand binding through interactions
with the b2–b3 loop region. In addition to residues at the binding
site and b2–b3 loop regions of PSD-95-PDZ3, NMR titrations of
PSD-95-PDZ3 with KKETAV also revealed chemical shift
perturbations for some residues located in the a3 helix (Figures 4
and S2), which comprises the ten C-terminal residues of PDZ3
(Figure 2). This C-terminal helix, which contains the Tyr397
phosphorylation site, is a distinctive element of the PSD-95-PDZ3
domain, as well as a few other members of the MAGUK family,
not displaying the canonical PDZ fold that only contains two a-
helices [30]. In principle, the binding behaviour of PSD-95-PDZ3
is not expected to be influenced by residues in the a3 helix because
this helix is located at a different surface of the protein, more than
5 Å away from the binding site for residue 23 in KKETAV
Figure 4. Chemical shift perturbation analyses of PSD-95-PDZ3 and D10ct-PDZ3 upon titration with KKETAV at pH 7.5. The 15N and
1H chemical shift perturbations (DdHN) of each amide were calculated using Equation 1 (see the Materials and Methods section). The numbers
indicate the residues in PSD-95-PDZ relative to their positions in the full PSD-95 protein. The secondary structures of PSD-95-PDZ3 are shown above
the graph.
doi:10.1371/journal.pone.0090030.g004
Post-Translational Modifications in PSD95-PDZ3
PLOS ONE | www.plosone.org 5 February 2014 | Volume 9 | Issue 2 | e90030
Figure 5. Different moments of the MD simulation of the PSD-95-PDZ3/KKETAV complex at pH 7.5. The upper panels show models of
the interactions of Lys-4 in KKETAV (orange) with Glu331 and Glu373 in PSD-95-PDZ3. The lower panels show models of the interactions between Lys-
5 in KKETAV and Glu331, Glu334, and Glu401 in PSD-95-PDZ3.
doi:10.1371/journal.pone.0090030.g005
Table 2. Frequencies of formation of some relevant salt-bridges after 400 ns of MD simulations of the PSD-95-PDZ3 constructs in
complex with KKETAV.
WT-PDZ3 D10ct-PDZ3 Y397E-PDZ3 P397-PDZ3 D332P-PDZ3
LIGAND - b2–b3 LOOP
Lys(25)-Glu331 20.0% 35.9% 8.8% 9.5% 6.1%
Lys(25)-Glu334 36.2% 39.1% 27.2% 0.1% 0.0%
Lys(24)-Glu331 37.2% 28.1% 51.7% 27.4% 46.3%
LIGAND – a3 HELIX
Lys(25)-Glu401 1.9% 0.0% 3.5% 5.4% 5.0%
Glu(23)-Lys403 0.1% 0.0% 4.4% 7.7% 0.0%
LIGAND - OTHER DOMAIN RESIDUES
Lys(24)-Glu373 19.8% 16.2% 14.5% 18.6% 14.0%
a3 HELIX - b2–b3 LOOP
Lys403-Glu331 2.7% – 2.3% 1.8% 0.0%
Lys403-Asp332 0.7% – 2.0% 0.2% 0.0%
Lys403-Glu334 0.0% – 0.3% 0.0% 0.0%
a3 HELIX - DOMAIN RESIDUES
Glu334-Arg399 39.7% – 34.0% 44.4% 66.2%
Lys355-Glu401 44.3% – 43.6% 0.0% 37.8%
TOTAL FREQUENCY OF INTERACTIONS BETWEEN PDZ3 AND Lys(24) AND Lys(25) IN THE LIGAND
PDZ3-Lys(24)(25) 76.3% 71.8% 76.8% 54.5% 63.0%
FREQUENCY OF NON-FORMATION OF THE Glu334-Asp399 AND Lys355-Glu401 INTERACTIONS
24.9% – 36.1% 55.6% 21.0%
doi:10.1371/journal.pone.0090030.t002
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(looking at the 3D structure, position 23 is the closest to the a3
helix residues; Figure 2), and the protein is folded properly in its
absence [21,36]. However, deletion of this helix drastically reduces
the binding affinity of PSD-95-PDZ3 for the 9-mer CRIPT
peptide TKNYKQTSV [9], suggesting that it acts as an extension
of the binding site for long peptide ligands containing residues at
positions 25 and beyond [28]. Accordingly, a more modest effect
of deletion of the a3 helix was also observed for shorter ligands
[28]. Based on the results of additional NMR relaxation
experiments and MD simulations, it was postulated that this
reduction in the binding affinity of PSD-95-PDZ3 caused by
deletion of the a3 helix is due to an allosteric effect that results in
an increased conformational entropy of the PDZ3 domain [9,33].
Here, truncation of the a3 helix of PSD-95-PDZ3 (to form the
D10ct-PDZ3 mutant) caused a two-fold reduction in its binding
affinity for the KKTEAV ligand (Table 1), which is similar to a
previous report of a six-fold reduction in the binding affinity of
PSD-95-PDZ3 for a shorter CRIPT fragment (YKQTSV) upon
deletion of this helix [28].
Despite this inhibitory effect of deletion of the a3 helix of PSD-
95-PDZ3, NMR titration experiments using 15N-labelled D10ct-
PDZ3 and KKTEAV produced a chemical shift perturbation
pattern very similar to that obtained for the full-length PSD-95-
PDZ3 domain titrated with KKETAV (Figures 4 and S2) or the 9-
mer CRIPT peptide [9]. Since the chemical environment of the
PSD-95-PDZ3 residues is affected in the same way by binding of
both of these ligands, a conserved binding mode that is
independent of the peptide ligand and the presence of the a3
helix is plausible. As discussed in the previous section, MD
simulations of the PDZ3/KKETAV complex structure did not
reveal any notable interactions between the peptide ligand and the
a3 helix region. Therefore, the perturbation of chemical shifts
identified for residues in the a3 helix of PSD-95-PDZ3 is most
likely not due to direct contacts that could eventually be
established for longer ligands, rather, perturbation of the a3 helix
may be caused by be an indirect mechanism.
The PDZ3/KKETAV model structure (Figure 2) includes salt-
bridges between Glu401 in the a3 helix and Lys355 in the b4
strand, and between Arg399 in the a3 helix and Glu334 in the b2-
b3 loop. As discussed above, Glu334 appears to play an important
role in KKETAV binding via interactions with Lys-5 in the ligand.
In a previous report, we proposed that these two salt-bridges are
responsible for the pH dependency of the unfolding of the PDZ3
domain, which changes dramatically below pH 3.5 due to salt-
bridge relaxation associated with the titration of solvent-exposed
Glu residues [32]. The results presented here support the concept
that the Glu401-Lys355 and Arg399-Glu334 salt-bridges play a
critical role in binding linked to the a3 helix region. To investigate
this hypothesis further, MD simulations of the PDZ3/KKETAV
complex and the truncated D10ct-PDZ3/KKETAV complex
lacking the a3 helix were performed. In the wild-type PDZ3/
KKETAV complex, the Arg399-Glu334 and Glu401-Lys355 salt-
bridges were formed for approximately 40% of the simulation time
(Table 2). The Glu401-Lys355 salt-bridge did not affect binding
dynamics, but the Arg399-Glu334 salt-bridge was established
whenever the Glu334 side chain was not interacting directly with
Lys-5 in the ligand (Figure S3). Upon the removal of the a3 helix,
the interaction of D10ct-PDZ3 with Lys-5 in KKETAV was
altered; specifically, the frequency of the interaction between Lys-5
and Glu331 was increased from 20% to 36% of the simulation
time, as well as the respective between Lys-5 with Glu334 (around
a 5%). Conversely, removal of the a3 helix reduced the frequency
of the interaction of Glu331 with Lys-4 in KKETAV (by almost a
10%), although the interaction between Lys-4 and Glu373 at the
binding site was maintained. Overall, these changes suggest
modulation of the b2–b3 loop dynamics upon helix truncation.
The general reduction in the interactions of the N-terminal Lys
residues, including the net drop in Lys-4 interactions, may explain
the reduction in binding affinity of PSD-95-PDZ3, which was
mostly enthalpic, upon removal of the a3 helix.
To investigate the contribution of salt-bridges to the binding
energetics of PDZ3 further, ITC was used to examine binding of
KKETAV to the mutated PSD-95-PDZ3 proteins E334Q-PDZ3
and E401R-PDZ3. The E401R mutation did not affect binding
(Table 1); however, the NMR studies did suggest that the a3
residues 401–403 influence the interaction between KKETAV
and PSD-95-PDZ. Specifically, a chemical shift movement greater
than 0.2 ppm occurred for these residues upon ligand binding
(Figure 4). Since the mutation analysis indicated that Glu401 does
not contribute energetically to the interaction between PSD-95-
PDZ3 and its ligand, these movements may be caused by the
interaction of Lys403 with several residues in the b2-b3 loop,
which were detected in the MD simulations of the PDZ3/
KKETAV interaction and would become weaker upon ligand
binding. On the other hand, the E334Q mutation reduced the
binding affinity of PSD-95-PDZ3 for its ligand by almost the same
magnitude (approximately two-fold) as that caused by removal of
the a3 helix (Table 1). Therefore, this single interaction between
the b2–b3 loop and helix a3 seems to account for the energetic
influence of the extra-helix upon ligand binding.
In summary, the results described above indicate that, although
it does not establish a direct contact with the ligand, the additional
a3 helix in PSD-95-PDZ3 plays a relevant role in ligand
recognition through stabilisation of the b2–b3 loop in a binding-
competent conformation. The following sections describe the
central role of this regulatory mechanism in the modulation of
PSD-95-PDZ3 binding properties through post-translational
modifications.
Phosphorylation of Tyr397 in the a3 Helix Regulates the
Binding Affinity of PSD-95-PDZ3
Tyr397 in the a3 helix of PSD-95-PDZ3 has been identified
previously as a phosphorylation site; therefore, we investigated the
influence of this post-translational modification on the regulatory
role of the a3 helix in PSD-95-PDZ3 interactions. First, we
examined the effect of mutation of Tyr397 on the binding affinity
of PSD-95-PDZ3 for KKETAV. The Y397E mutation reduced
the binding affinity from 1.5 mM to 2.7 mM and caused a marked
enthalpic change (DDHY397E = 2.4 kcal?mol
21), which was com-
pensated by entropic changes (Table 1). These results indicate
that, although the effect of the Y397E mutation on the dissociation
constant was fairly modest, considerable changes in the molecular
interactions occurred. To explore these molecular changes further,
MD simulations of the Y397E-PDZ3 mutant were performed. The
introduction of an additional negative charge at position 397 by
the Y397E mutation led to an approximate 10% decrease in the
frequencies of occurrence of the interactions between Lys-5 in the
ligand and the negatively-charged Glu331 and Glu334 residues in
the b2–b3 loop, as well as an approximate 10% increase in the
frequency of interaction between Glu331 with Lys-4 in the ligand
(Table 2).
The structural model of the PDZ3/KKETAV shows that the
interface between the a3 helix and the PDZ3 core contains a high
density of negatively-charged residues, including Glu334 from the
b3 strand, Glu396 and Glu401 from the a3 helix, and a number of
others (Figure 2, right panel). The introduction of an additional
negative charge at position 397 would strengthen the electrostatic
repulsions and may result in opening of the C-terminal a3 helix, as
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suggested by a previous NMR study [36]. This concept is
supported by our previous folding studies, which showed that
PSD-95-PDZ3 unfolds as a two-state protein at pH values lower
than 3.0, at which Asp and Glu residues are protonated [32]. At
higher pH values, electrostatic repulsion caused by the negative
charges present at the interface between the a3 helix and the
PDZ3 core results in suboptimal packing of the a3 helix and a
more complicated three-state unfolding process. In this previous
study, a3 helix interactions were estimated to contribute up to
10 kcal?mol21 to PSD-95-PDZ3 unfolding enthalpy [32].
Thus, the data described above suggest that Glu residues at the
a3 helix/PDZ3 interface have opposing effects on protein
conformation: the above mentioned repulsive effect and a
favourable effect arising from the establishment of the Lys355-
Glu401 and Glu334-Arg399 salt-bridges. To evaluate this a3 helix
conformational flipping, MD simulations were used to estimate the
total frequencies of occurrence of the Lys355-Glu401 and Glu334-
Arg399 salt-bridges. Because these salt-bridges are located in the
two regions where the helix is packed (the b4 strand and the b2–b3
loop), we assumed that the helix was not attached to the PDZ
domain in the absence of salt-bridge formation. Conversely, when
at least one of the salt-bridges was formed, we assumed that the
helix was attached to the PDZ3 core. As shown in Table 2, the
frequencies of non-formation of the salt-bridges in the KKETAV
complexes between wild-type PDZ3 and the Y397E-PDZ3 mutant
were 25% and 36%, respectively, indicating that the Y397E
mutation promotes the open conformation of the protein complex.
Therefore, the introduction of an additional negative charge at
Tyr397 in PSD-95-PDZ affects conformational flipping between
the docked and undocked forms of the a3 helix.
Next, MD simulations of the Y397E-PDZ3 mutant and PDZ3
containing phosphorylated Tyr397 (P397-PDZ3) were performed.
The Y397E mutation had no effect on the frequency of occurrence
of interactions between Lys-4 and Lys-5 and the PSD-95-PDZ3
domain, but phosphorylation of Tyr397 caused a dramatic
reduction in this frequency from 76% to 55% (Table 2). Notably,
unlike the Y397E mutation, phosphorylation of Tyr397 caused
movement of the ligand in the PDZ3/KKETAV complex.
Specifically, the KKETAV peptide translocated from the binding
pocket, such that its Lys-4 residue was positioned in close
proximity to the phosphate group on Tyr397 and a salt-bridge
between Lys-5 and Glu401 was formed and maintained until the
end of the simulation (Figure 6). Furthermore, phosphorylation of
Tyr397 caused the formation of intra-domain interactions
between Lys403 at the C-terminus of the a3 helix and the
negatively-charged Glu331 and Asp332 residues in the b2–b3
loop. Although we do not believe that this peptide movement
reflects the real dynamic features of the interaction between PSD-
95-PDZ3 and KKETAV, it does reveal the high electronegative
potential generated by Tyr397 phosphorylation. This effect of
Tyr397 phosphorylation was even more evident when helix
flipping of PSD-95-PDZ3 was examined. The frequencies of non-
formation of the Glu334-Arg399 and Lys355-Glu401 salt-bridges
in the wild-type PDZ/KKETAV, Y397E/KKETAV, and P397-
PDZ3/KKETAV complexes were 25%, 36%, and 56%, respec-
tively (Table 2). These results indicate that phosphorylation of
Figure 6. Peptide ligand freedom during MD simulations. The upper panels display peptide ligand (orange) freedom during MD simulations
of the PDZ3/KKETAV (upper left panel) and P397-PDZ3/KKETAV (upper right panel) complexes. The lower panels display different moments of the MD
simulations with the PDZ3/KKETAV (lower left panel) P397-PDZ3/KKETAV (lower right panel) complexes, showing the displacement of the KKETAV
ligand towards phosphorylated Tyr397 residue.
doi:10.1371/journal.pone.0090030.g006
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Tyr397 promotes helix flipping and formation of the open
conformation more effectively than the Y397E mutation, most
likely due to the fact that the electronegative potential is increased
by the additional negative charge of the phosphate group
compared to Glu. Moreover, the Y397E mutant does not contain
the aromatic electrons of Tyr397 and the p-electron clouds of the
aromatic rings of residues at the interface between the PDZ3 core
and the a3 helix will also contribute to helix flipping to some
degree. Indeed, a previous study demonstrated that phosphoryla-
tion of Tyr397 reduced the binding affinity of PSD-95-PZD3 for
the CRIPT peptide from 3.6 mM to 14.0 mM [11].
Truncation of the a3 helix is not expected to replicate the
reduction in binding affinity of PSD-95-PDZ3 for KKETAV
caused by phosphorylation of the Tyr397 residue because helix
flipping will not occur and the absence of this helix will not
reproduce the almost pure entropic nature of the reduction in
affinity caused by the additional phosphate group. Furthermore,
another entropic source may also contribute to the increased
freedom that the peptide experiences at the binding pocket upon
inclusion of the extra phosphate group (Figure 6). These entropic
factors were not observed upon deletion of the a3 helix. The
binding affinity of D10ct-PDZ3 for KKETAV was only two-fold
lower than that of wild-type PDZ3; this reduction was mainly
enthalpic in nature (Table 2) and, as mentioned above, can be
qualitatively explained by redistribution and reduction of the
interaction frequencies of Lys-4 and Lys-5 in the ligand. Overall,
the results presented here demonstrate that the b2–b3 loop plays a
critical role in PDZ3 binding due to direct interaction with the
peptide and with the a3 helix. They also show that phosphory-
lation can regulate binding by disturbing the helix, with the
concomitant alteration of the b2-b3 loop.
Succinimide Cyclation of the Asp332 Side Chain Affects
the Binding Properties of PSD-95-PDZ3
As mentioned earlier, cyclation of the Asp332 residue to a
succinimide ring may affect the binding affinity of PSD-95-PDZ3.
Succinimide formation is a spontaneous chemical modification of
Asp and Asn residues located preferentially at loops or exposed
regions in proteins in which the side chain cyclises. We reported
previously that Asp332 in the b2-b3 loop of PSD-95-PDZ3 can
undergo spontaneous succinimide formation at neutral pH during
the crystallisation process [12]. To determine if this succinimide
ring is stable in solution, a collection of SNN332-PDZ3 crystals
were dissolved in 50 mM potassium phosphate (pH 7.5) buffer and
the spontaneous side chain linearisation kinetics were followed by
mass spectrometry. The molecular weight reduction of 18 Da
associated with succinimide formation was used as an indicator of
the population of linearised side chains at different time points.
The mass spectrometry peak corresponding to the molecular
weight of succinimide was reduced by almost 50% after 1 h and
disappeared fully within 24 h. These data indicate that, despite its
transient nature, the succinimide ring in PSD-95-PDZ3 is stable
enough to influence its binding properties. Unfortunately, the
kinetic nature of the process precludes a direct experimental
investigation of its effects on binding thermodynamics. Consider-
ing that the proline ring is structurally very similar to the
succinimide ring, and that Asp332 does not interact with Lys
residues in the peptide ligand or with the a3 helix residues in PSD-
95-PDZ3, we generated and used the D332P-PDZ3 mutant as an
acceptable model of succinimide formation. The effects of this
mutation on the binding energetics and conformational equilib-
rium of the protein were examined by MD simulations.
ITC analyses of the interaction between KKETAV and D332P-
PDZ3 in 50 mM potassium phosphate (pH 7.5) revealed that the
D332P mutation reduced the binding affinity of PDZ3 for
KKETAV dramatically (wild-type PDZ3, 1.5 mM; D332P-
PDZ3, 16.0 mM), as reflected by a less favourable binding
enthalpy (Table 1). In agreement with this result, MD simulations
also showed that this mutation reduced the percentage of time
during which Lys-4 and Lys-5 in the ligand formed at least one
salt-bridge with PSD-95-PDZ3 from 76% to 63% (Table 2).
Notably, the reduction in binding affinity caused by the D332P
mutation was associated with almost complete loss of the salt-
bridges between Lys-5 in the ligand and the Glu331 and Glu334
residues in the b2–b3 loop of PDZ3, which were established in the
wild-type PDZ3/KKETAV complex for 20–36% of the simula-
tion time (Table 2). Conversely, the D332P mutation did not affect
the interaction between Lys-4 and PDZ3 or the helix flipping
frequencies (Table 2). Therefore, the lower binding affinity of
D332P-PDZ3 compared with wild-type PDZ3 may be due to a
reduction in the conformational freedom of the b2-b3 loop caused
by the proline ring, which impairs the establishment of interac-
tions.
The results described above suggest that the b2–b3 loop of
PSD-95-PDZ3 is a key determinant of binding affinity. To provide
additional evidence for this theory, we determined the effect of the
D332G mutation on the binding affinity of PSD-95-PDZ3 for
KKETAV. The D332G mutation caused a loss of binding affinity
similar to that caused by the E334Q mutation (Table 1), indicating
that the additional conformational freedom in the b2–b3 loop
caused by the glycine residue has similar effect on binding affinity
as relaxation of the Glu334-Arg399 salt-bridge. These results
support the concept that the dynamic properties of the b2–b3 loop
determine the binding affinity of PDZ3 and that the a3 helix
exerts a regulatory effect simply by influencing this dynamic
behaviour through the Glu334-Arg399 interaction. From a
dynamic point of view, succinimide formation has a similar effect
on binding but is achieved in a different way, namely by limiting
the conformational freedom of the b2–b3 loop. Although
mutations may not be relevant to regulation of PDZ3 binding
in vivo, similar effects may be achieved by post-translational
modifications, such as those described here.
The Effects of Post-translational Modifications on the
Regulation of PDZ3 Binding
Although it is not the first example of modulation of the binding
activities of PDZ family members [37–41], the regulation of the a3
helix of PSD-95-PDZ3 has some interesting features. As demon-
strated here and in previous studies, the absence of the a3 helix
does not drive conformational changes in PDZ3 [9,21,36].
Nevertheless, the a3 helix modulates the dynamics of the side
chains, mainly those of Glu334 and Arg399 that connect this
extra-helix with the b2–b3 loop. According to the MD analyses
described here, the dynamics of this loop is central to the control of
binding of linear peptides to PDZ3, since positively-charged
residues in ligands at positions 24 or beyond interact with the
negative carboxylates of Glu331 and Glu334 in the b2–b3 loop.
This interaction network is essential for binding because peptides
shorter than four residues do not bind to PDZ3 [19]. Previous MD
simulations have shown that PDZ3/peptide binding is also
regulated by the formation of an additional salt-bridge between
residues Lys355 and Glu401, which are postulated to connect the
a3 segment with the well-conserved carboxylate binding loop
through a hypothetical network of interactions within PDZ3 [33].
However, as mentioned above, the E401R mutation did not affect
the binding affinity of PSD-95-PDZ3 for the KKETAV peptide
(Table 1).
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The results presented here suggest that the modulatory effect of
the a3 linker sequence (which connects the SH3 domain and the
remainder of the PDZ3 and is positioned far away from the
binding pocket) on the binding affinity of PSD-95-PZD3 is not
caused by a conformational change or the existence of a
intramolecular network. On the contrary, it seems that this
modulatory effect is attributable to a much simpler mechanism
involving a salt-bridge that connects the a3 helix to the b2–b3
loop. Moreover, the formation of this salt-bridge competes with
others established between three negatively-charged residues of the
b2–b3 loop and two positively-charged residues in the peptide
ligands. These positive charges are well conserved amongst
different peptide ligands described for PSD-95-PDZ3, all of which
contain at least one Lys and/or one His residue at positions 24
and beyond [19]. This relatively simple mechanism explains the
reduction in the binding affinity of PSD-95-PDZ3 for KKETAV
upon phosphorylation of Tyr397, which is located in the a3 helix.
As mentioned above, the interface between the a3 helix and the
PDZ3 core contains a high density of negative charges (Figure 2,
right panel), resulting in electrostatic repulsion under neutral pH
conditions. The p-electron clouds of the aromatic rings of Phe337
in the b3 strand and Tyr397 and Phe400 in the a3 helix may also
form anion-p interactions that contribute to the electrostatic
repulsion (Figure 2, right panel). Therefore, as described above,
the introduction of additional negative charge through phosphor-
ylation of Tyr397 promotes flipping between the docked and
undocked forms of the a3 helix. This strong interfacial negative
potential is supported by substantial conformational freedom of
the peptide, which is able to pull out from the binding pocket, as
demonstrated by MD simulations with P397-PDZ3. These effects
translate into a reduction in the net frequency of interactions
between both Lys residues of the peptide ligand and the
negatively-charged residues of the b2-b3 loop in PDZ3, thereby
reducing the binding affinity in a mainly entropic manner.
The reduced binding affinity of the D332P-PZD3 mutant,
which simulated cyclation of Asp332 into a succinimide ring, is
comparable to the binding affinity reported for the P397-PDZ3/
CRIPT complex in a previous study [11]. Asp332 did not interact
with any residue of the KKETAV ligand, but mutating Asp332
modulated the conformational properties of the b2–b3 loop and
consequently the stability of the salt-bridge network between this
loop and the positively-charged residues in the ligand. The
dynamics of the a3 helix did not seem to affect binding in this case,
since the formation of the Lys355-Glu401 and Glu334-Asp399
salt-bridges was not affected appreciably by the D332P mutation
(Table 2).
Conclusions
In summary, interplay of the salt-bridges between the a3 helix
and b2–b3 loop of PSD-95-PDZ3 and the positively-charged
residues of the ligand peptide can account for the regulatory effects
of post-translational modifications of PDZ3, both energetically and
dynamically. The observed interactions between residues in the a3
helix and the b2–b3 loop may exist in nature when the SH3
domain that follows the a3 helix is present. Therefore, it is possible
that the C-terminal tails of ligand proteins compete with the salt-
bridge network. The positive charges at the C-terminus of a ligand
protein will contribute to the disorganisation of the naturally-
occurring inter-domain associations. In addition, the chemical
shift dispersion with the KKETAV peptide described here is
similar to that reported for the CRIPT peptide previously [9],
suggesting that this regulatory mechanism is universal for ligand
binding to PDZ3. Overall, the results presented here demonstrate
that post-translational modifications of PSD-95-PDZ3 are potent
and simple regulators of ligand binding that might trigger the
delivery or capture of a target, thereby facilitating the complex
biological role of the MAGUK protein PSD-95 in vivo.
Supporting Information
Figure S1 Calorimetric titrations of the PSD95-PDZ3
mutants with the ligand KKETAV at 25 uC in 50 mM
potassium phosphate (pH 7.5). Upper panels: net heat
effects, after dilution substraction, associated with the injection
of KKETAV (see Materials and Methods for details). Lower
panels: ligand concentration dependence of the heat released upon
binding after normalization and correction for the heats of
dilution. Symbols represent experimental data and the continuous
line corresponds to the best fitting to a model considering one set
of binding sites.
(DOCX)
Figure S2 Chemical shift perturbation experiments of
PDZ3 and D10ct-PDZ3 upon titration with KKETAV at
pH 7.5. The panels show the extent of the perturbation for every
residue of PDZ3 (left) and D10ct-PDZ3 (right) as a colour code:
blue for Dd values ranging from 0 to 0.2 ppm; yellow for 0.2 to
0.5 ppm; red for Dd values higher than 0.5 ppm.
(DOCX)
Figure S3 Distance values between residue Glu334 and
either Lys-5 (red) or Arg399 (blue) along the 400 ns
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